Back to User profile » Dr Douglas W Mapel
Papers published by Dr Douglas W Mapel:
Disease Burden and Health-Related Quality of Life (HRQoL) of Chronic Obstructive Pulmonary Disease (COPD) in the US – Evidence from the Medical Expenditure Panel Survey (MEPS) from 2016-2019
Roberts MH, Mannino DM, Mapel DW, Lunacsek O, Amin S, Farrelly E, Feigler N, Pollack MF
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:1033-1046
Published Date: 13 May 2024
Frailty Among Older Individuals with and without COPD: A Cohort Study of Prevalence and Association with Adverse Outcomes
Roberts MH, Mapel DW, Ganvir N, Dodd MA
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:701-717
Published Date: 5 April 2022
Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Mapel DW, Roberts MH, Sama S, Bobbili PJ, Cheng WY, Duh MS, Nguyen C, Thompson-Leduc P, Van Dyke MK, Rothnie KJ, Sundaresan D, Certa JM, Whiting TS, Brown JL, Roblin DW
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1687-1698
Published Date: 9 June 2021
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1825-1836
Published Date: 21 June 2017
Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity
Mapel DW, Dalal AA, Johnson PJ, Becker LK, Hunter AG
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1477-1486
Published Date: 29 July 2015
The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease
Roberts MH, Mapel DW, Thomson HN
ClinicoEconomics and Outcomes Research 2015, 7:173-184
Published Date: 26 March 2015
Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD
Mapel DW, Marton JP
International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:127-134
Published Date: 15 March 2013
Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients
Make B, Dutro MP, Paulose-Ram R, Marton JP, Mapel DW
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:1-9
Published Date: 18 January 2012